1823574879
PsyQ: Foundations of Psychopharmacology

Advertise on podcast: PsyQ: Foundations of Psychopharmacology

Rating
★★★★★
5
from
3 reviews
This podcast has
14 episodes
Language
English
Date created
2025/06/30
Latest episode
2026/03/16
Average duration
33 min.
Release period
20 days

Description

This is an AI generated podcast. Master the 'why' behind the medications you prescribe. PsyQ: Psychopharmacology Foundations provides clear, expert-reviewed summaries covering the molecular bases of psychopharmacology. We break down complex mechanisms of action, receptor pharmacology, and neurobiology for busy psychiatry residents and clinicians. We leverage AI tools to kickstart the summary process, followed by human review and contextualization to ensure accuracy and clinical relevance. Your essential audio reference for the science of psychopharmacology. These are merely summaries meant to improve access through convenience, please be mindful that inaccuracies may be present - please refer to the original source material for the most accurate and representative information. upathak.substack.com

Unlock PsyQ: Foundations of Psychopharmacology podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from PsyQ: Foundations of Psychopharmacology podcast


Psychedelic-Assisted Therapies for Older Adults - PsyQ Episode 40
2026/03/16
In this episode of PsyQ, the hosts discuss the 2023 article "The safety and efficacy of psychedelic-assisted therapies for older adults: Knowns and unknowns". They explain the physiological mechanisms of substances like psilocybin and MDMA, noting how they suppress the "Default Mode Network" to facilitate new neural pathways and promote neuroplasticity. While clinical trials show promise for treating major depression, end-of-life distress, and PTSD, the hosts emphasize a significant "demographic disconnect". Current research primarily involves young, healthy participants, yet older adults present complex medical realities, including polypharmacy and cardiovascular vulnerabilities. Specifically, the stimulation of 5-HT2A receptors can cause vasoconstriction and increase blood pressure, posing risks of stroke or arrhythmia in geriatric patients. The discussion concludes that while psychedelics offer a "breakthrough" potential for mental health, rigorous trials focused on the elderly are essential to determine if these high-dose therapies can be safely adapted for aging bodies. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 13: Impulsivity, Compulsivity, and Addiction
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 12: Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 11: Attention Deficit Hyperactivity Disorder and Its Treatment
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 10: Disorders of Sleep and Wakefulness and Their Treatment
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 9: Chronic Pain and Its Treatment
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 8: Anxiety, Trauma, and Treatment
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 7: Treatments for Mood Disorders
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 6: Mood Disorders and the Neurotransmitter Networks Norepinephrine and GABA
2025/06/30
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 5: Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond
2025/06/29
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 4: Psychosis, Schizophrenia, and the Neurotransmitter Networks
2025/06/29
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 3: Ion Channels
2025/06/29
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 2: Transporters, Receptors, and Enzymes
2025/06/29
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com
Chapter 1: Chemical Neurotransmission
2025/06/29
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit upathak.substack.com

Podcast reviews

Read PsyQ: Foundations of Psychopharmacology podcast reviews


5 out of 5
3 reviews
★★★★★
Magicmarker92 2026/01/07
Excellent summaries
I felt ethically uneasy about using an AI podcast, and it is a little eerie hearing how it mimics typical radio hosts’ style of speaking. But perhaps ...
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on PsyQ: Foundations of Psychopharmacology relevant audience podcasts


What do you want to promote?